title: MYCN amplification remains prognostically strong 20 years after its "clinical debut".
authors.forename: Susan L
authors.initials: SL
authors.lastname: Cohn
authors.forename: Deborah A
authors.initials: DA
authors.lastname: Tweddle
mesh_terms: D015139:Blotting, Southern; D002648:Child; D005784:Gene Amplification; D016259:Genes, myc / Q000235:genetics*; D006801:Humans; D009447:Neuroblastoma / Q000235:genetics*; D011379:Prognosis